-transparent.png){kind=logo}
Human placental tissue and human trophoblast cells (JAr) were examined after exposure to the anti-HIV nucleoside analog AZT (Zidovudine) for the presence of 3'-amino-3'-deoxythymidine (AMT), a toxic catabolite. Placental cells were exposed to 7.6 mM AZT for 48 hr, and placental lobular tissue was perfused with 3.8 mM AZT for 14 hr. Cell homogenates were prepared, and supernatants were subjected to HPLC analysis. Despite large cellular concentrations of AZT, AMT was not detected in any of the samples analyzed. Exposure of JAr cells to this concentration of AZT produces a 72% inhibition of cell proliferation when compared with unexposed controls. Based upon the results of the current study, AMT was not formed by placental cells exposed to AZT and, thus, not a mechanism for toxicity after in vitro exposure to AZT.
M A Plessinger, and
J H Boal, and
R K Miller
February 1990,
The Journal of infectious diseases,
M A Plessinger, and
J H Boal, and
R K Miller
October 2003,
Toxicology and applied pharmacology,
M A Plessinger, and
J H Boal, and
R K Miller
March 1998,
Biochemical pharmacology,
M A Plessinger, and
J H Boal, and
R K Miller
May 1996,
Journal of immunoassay,
M A Plessinger, and
J H Boal, and
R K Miller
April 1988,
Acta crystallographica. Section C, Crystal structure communications,
M A Plessinger, and
J H Boal, and
R K Miller
July 1994,
Biochemical pharmacology,
M A Plessinger, and
J H Boal, and
R K Miller
June 1992,
Clinical pharmacology and therapeutics,
M A Plessinger, and
J H Boal, and
R K Miller
May 1992,
Antimicrobial agents and chemotherapy,
M A Plessinger, and
J H Boal, and
R K Miller
July 1999,
Mutation research,
